Boshi Medical Cloud Secures Tens of Millions of RMB in Series A Funding from Matrix Partners China to Enhance Clinical and Research Efficiency

VCBeat (WeChat Official Account: vcbeat) exclusively learned on June 28 that Suowen Boshi, a leading domestic medical big data and artificial intelligence company, announced that it had securedMatrix Partners ChinaofTens of millions of RMB in Series A investment. China Renaissance Alpha served as the exclusive financial advisor for this financing round.

Suowen Boshi was founded in 2014, and the company's core products“Boshi Medical Cloud”It is currently a leading cloud-based database and electronic medical record platform in China, featuring disease specialization and structured data. It covers major disease areas such as oncology, hematology, orthopedics, neurosurgery, and neurology, across ChinaOver 400 Grade A tertiary hospitalsof over2,700 Clinical DepartmentsImplemented practical applications.Among them, there are over 1,200 departments related to oncology (including hematologic malignancies).

Guo Yulan, Co-founder and CEO of the company, graduated from Peking University Health Science Center and worked for many years in the Investment Banking Division of China International Capital Corporation (CICC). Liu Xi, Co-founder and Co-CEO, also graduated from Peking University Health Science Center and has over 10 years of experience in pharmaceutical sales. Du Wei, Co-founder and CTO, graduated from the Department of Computer Science and Technology at Tsinghua University, with more than 10 years of experience in enterprise-level data system development, and has been named a Microsoft Most Valuable Professional (MVP) for multiple consecutive years.

In terms of honors, Boshi Medical Cloud has been designated as a specified data platform or showcased as an outstanding case by multiple professional physician organizations, including the Trauma Group of the Orthopaedics Branch of the Chinese Medical Association, the Chinese Hemophagocytic Lymphohistiocytosis Alliance, the Neurology Group of the Research Hospital Association, the Northern Cooperative Group for Multiple Myeloma, the Beijing Thoracic Surgery Branch of the Chinese Medical Association, the Spinal Orthopaedics Branch of the Chinese Medical Association, and the National Cooperative Group for Bone Tumors of the Chinese Medical Doctor Association.

VCBeat recently broke the news that Suowen Boshi had joined forces with the Data Science Center of the Chinese Academy of Sciences (CAS) to establish a Joint Laboratory for Medical Big Data. According to the report, experts from the CAS Data Science Center will collaborate with clinicians on the Boshi Medical Cloud Platform to contribute to the in-depth exploration and application of medical data in China.

Guo Yulan, Co-founder and CEO of the company, stated to VCBeat: “China has a large patient population, with medical data originating from diverse sources and exhibiting low levels of structuring. Meanwhile, the pace of development across various disease fields continues to accelerate. For many years, frontline clinicians have eagerly sought a specialized, comprehensive digital tool capable of managing patient data and facilitating scientific research. Such a tool should feature disease-specific specialization, structured data handling, and the ability to be rapidly upgraded and adjusted.”

In response to this need, we recognized that traditional technical approaches could not effectively meet physicians’ demands. During the first eighteen months after the company’s founding, we interviewed numerous clinical experts and devoted ourselves to developing core underlying technologies and tools. Aligning closely with physicians’ practical needs, we created the Boshi Medical Cloud product. Since its launch in the fourth quarter of 2015, it has gained broad market recognition and become a highly regarded and popular “clinical department-level tool” among physicians in China.

"In the future, we will continue to upgrade our products and services, integrate professional resources across various disease areas, and combine deep learning algorithms with data science technologies to provide better and more convenient services to a broader range of clinicians, ultimately bringing health wealth to patients."

Sun Linghao, Investment Manager at Matrix Partners China, stated: “Boshi Medical Cloud is dedicated to optimizing the workflows of Chinese clinicians and continuously enhancing the efficiency of clinical diagnosis, treatment, and scientific research. Over the past year, the company has achieved significant progress in business development, earning high recognition from a broad base of clinical experts in major disease areas such as solid tumors and hematologic malignancies. We maintain a long-term positive outlook on investment opportunities at the intersection of data and healthcare, and are committed to supporting outstanding teams in this field.”